How much does a box of Datopotamab cost?

Datopotamab (Datopotamab) is an innovative TROP2-targeted antibody drug conjugate (ADC) that represents a new direction in antibody drug conjugate therapy. Its design concept is to combine antibodies that accurately recognize tumor cells with potent cytotoxic drugs to ensure efficacy while minimizing systemic side effects. Currently, the drug has been approved by the FDA and the European Medicines Agency for the treatment of a variety of solid tumors, especially in advanced breast cancer and non-small cell lung cancer (NSCLC), showing significant therapeutic potential. In 2025, dabrotuzumab will be approved for marketing in China, marking that domestic patients will also be able to obtain this new treatment option through specific channels.

In terms of price, the cost of dabrotuzumab is still high. According to overseas market data in 2025, the price of the American version of Datroway (100mg/bottle) is about 60,000 yuan, while the European version is slightly lower, about 30,000 yuan per bottle. Since the drug has not yet entered China's medical insurance reimbursement list, patients currently mainly purchase it through commercial insurance or self-pay. In addition, because it is a high-tech ADC drug with complex production processes and expensive raw materials, the possibility of price reduction in the short term is small. It is worth noting that there are currently no approved generic drugs in the world, so the price difference is mainly reflected in import channels and taxes.

Overall, the advent of dabrotomab not only broadens the boundaries of advanced tumor treatment, but also reflects the development trend of precision medicine. Although the price is relatively high, its potential to improve the quality of life and extend survival still makes it a high-profile drug in the field of cancer treatment. In the future, as domestic production and medical insurance negotiations advance, Datopotamab is expected to gradually achieve wider accessibility.

Reference materials:https://www.google.com.hk/